Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Compounds promoting proteoglycan production claimed by Sumitomo

Jan. 5, 2001

Recombinant AnergiX.RA to be codeveloped by Corixa and Organon

Jan. 5, 2001

Recent patent covers MMP and TACE inhibitors from Fuji Yakuhin

Jan. 4, 2001

Therapeutically useful metalloproteinase inhibitors designed at Darwin Discovery

Jan. 4, 2001

Hydroxamic acid-based MMP inhibitors with selectivity for MMP-2, MMP-9 and/or MMP-13

Jan. 3, 2001

Remicade is first drug approved for inhibiting progression of joint damage in RA

Jan. 3, 2001

BP-2-94: an H3 receptor agonist prodrug with an interesting antiinflammatory/antinociceptive profile

Jan. 2, 2001

Abgenix's ABX-IL-8 enters phase II evaluation for rheumatoid arthritis

Dec. 29, 2000

Otsuka reveals thiazole derivatives with potential broad therapeutic application

Dec. 28, 2000

Pfizer presents new mu-selective opioid receptor ligands and use thereof

Dec. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...